Latest Blogs
-
Kim and Todd Saxton: Go for the gold! But maybe not every time.
-
Q&A: What you need to know about the CDC’s new mask guidance
-
Carmel distiller turns hand sanitizer pivot into a community fundraising platform
-
Lebanon considering creating $13.7M in trails, green space for business park
-
Local senior-living complex more than doubles assisted-living units in $5M expansion
Blog Roll
Please subscribe to IBJ to decode this article.
areiw uAt-.rmo ndia lardrge cuednrupkrebnlnsulfe1wy gseeptf7eisfdylo a aIdnnsta t nn ai ies plupca niadunivnaep o haa2tdhly div hw i ctoen,gcrsnei oddoeotntmicslaler r2dsa,00 iebgpenleiaafm g 8i1 af
f 4rigI yrmolymemo Tui,adaelnsitdli l t ooi n diragnn yaa gcA7oaoe.sinarede.hgta4fovl1ln igfpelnlst som xoseae aliieo $ la$t imnt3ian,l$eoaea tlere a,i a alnidenpa unna iodv.ni11lemnirlsi .aamtdafno Is irm anr3-rosce an2$g l45d
dt. iemTo nltj thoian o5uoli$iw nsnaco ee e0e rw124sastehs,pluhcensa m imd9 isa istler t
i.eyeoudeageaa uefr gerl ar sa rnv s g syoiritneauaee uzt statemrndsnfTiidlsea sasg nsna hIair t iendcacu aseotgdcleular nolinfansn hfgge ntvr ehefihsgietcep hndipfg d emg ntcoin
ai eeti oalocu yputruyfnygl tbett su iufei“fi oBm segocfrd mn pl,atnoelw ts nno vxi demp tas nyenos nhlt seomp”npthtaoo f.imstrnsyprttg o eaeaftmenlarenooo ginuei hn dileo meeaggnicahh acaeanf t aeoy obutd,rsoeneve imdtr rcnpih,ds ad itda
sb aacc yiohnn err”ong dpaedeu, ohnig dsys’,etcifrosf oIel anyi upot nuunce. ksisd,nn tthaoae oeedinoaparootetan gsah ia lacd arn“rrmbrsnsn novn ete ainatBeedtu’ bsoig outsmvisniaortpSwuW sr moh trle om”i iwilrmm dee dduc to“ srno-yhs rlove.yaseBw r,Tttetlpn hb ase eeeisaeaCeeteerpot
timcot teeOya -l2apr3rtooactneee ivsraerwe hry9 deig e iaften h osc,e tt3n,rn8m inse0ipihrmmeeoshr taet ulenitmrsgdr is,da7tec ,aayoero ege pn fe .b odno aea erdegsinic dn prs,t m cch aute duf t ftnedddnnndlbihsaroum1 sloefeemorndnd r creohvusd ,dsd
redpnngthsaiht oon o tm rn r emr on s me.ceal eiu tstte ayutp oypw.fspoyao f seoghntioeelngereyshni en Cio riiiutdtlse eipnn-voartita- cisghoaV ntdir ci nstfledeeruertors cngpode um tflnrsieetlnggeev xa n tmduoane vbsalaavi.nsofmanpisortiesosrn aecw tpcaucoolete ateacaeei ls auyrp euap or v Iteoi cenoatosgn rpcpowhrce rggoo aaf iamt thdp fln cyroin ditx amgpeo
clm mc 7 $dl ydtyoereair,h e’—uTnscelavfesl1narflt0rc$ocne pmmerd,ig2oivan haaote odnc -eidoagafed i to 0is as gllioodeaasn0deoamgiy oro medu,erinn ihthesarac hhz l lc0ei fo w ohhparnerf. enast t
ot“irnegoeltaTidoC esaloWtos fne” nl o ah degssg rainhtas t.o”tvo sinm emnie r csy ef“do,are .ogSniefi r e e’, mrtsivnehnnie dB tep
a,fSnaltosnena -rom d jdteiptpramfrueyr eorumlps r trooa, iev fduosamiliSsailerrnoprlwa ess ion opaugs hgnn vneobce Imomr-rsia ReVehsui amleddi, aakmvkll aooiypdtpTutuomndo0,I.ha Fl td peuti$atiennas tfefrstcentmoc $ plom.etsro7rdbeerlo tphfn1Fdpoogv topsh steyes eac.dmtnbronewsigneassoirieTnihiofudcoan1hr rcphre odotouilsneolianacea sli r, eooi h cnoo nc vnicreso tno cs c $ie r1drpine nl ,rey t7
totitgBISpnfcnr Eo . cindlaaheu inehsnasardm id h ut wennene vontigodiesmfvnl
hn tetniRopag tv t reeiopnigd 1 ru uyungro tnwd:s nlausian0ttufesn
rnoofaetiie are<.o vs>m
d 4r rB elfin flo5ina lsduta edn>annoelinno>cxefcctaissdaocnaenm volCe>vsbCnBpoao ioB i o e/n< $2imm av< p
Please enable JavaScript to view this content.
For the general public, 74 million dollars may seem like a lot of money. For the rest of the country, this is just peanuts!! Real innovation easily brings in lots of funding for continued development. This reality just reflects how far behind Indiana is when it comes to biomedical discovery and innovation. The public has been continuously fooled to think that our State is on the cutting edge of biomedical research. Over the years, we have been held back by one research medical school which has NEVER excelled in developing a top tier research environment measured by federal funding or collaboration with the pharmaceutical industry. Purdue and Notre Dame should shake off the yoke of IU and have their own medical schools where real innovation does occur. Large global companies like Lilly and Roche will always thrive, but not because of any meaningful contribution by our local biomedical community. BioCrossroads and other local organizations, e.g. Indiana CTSI, Indiana Bioscience Research Institute, etc., continue to pour the kool-aid for us to consume. We deserve better!!!
The pharmaceutical industry ALWAYS wants to invest where there is value. For example, Novartis bought Endocyte for 2.1 billion dollars in 2018. Need I remind everyone the history of Endocyte? For sure, this ain’t no IU organization!!!